Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Intercenter Variability in the Application of Biopsy-based Transcriptomics in Kidney Transplantation

P. Hruba, E. Girmanova, M. Novotny, T. Reischig, I. Gala, MM. Kubisova, Z. Lys, J. Zieg, Z. Zilinska, I. Dedinska, K. Krejci, M. Konkolova, V. Hanzal, P. Mrazova, L. Capkova, L. Voska, M. Kment, O. Viklicky

. 2025 ; 11 (10) : e1848. [pub] 20250918

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25020322

BACKGROUND: Biopsy-based transcriptomics (BBT) was implemented in Central Europe in 2022 to improve kidney transplant diagnostics. Differences in diagnostic practices across transplant centers remain underexplored. METHODS: This retrospective multicenter study analyzed 474 kidney graft biopsies from 10 transplant centers between August 2022 and May 2024, where, besides routine histology, BBT using the Molecular Microscope Diagnostic System (MMDx) was performed. Differences in BBT indications and discrepancies between histology assessment by Banff 2022 and MMDx sign-outs among transplant centers were evaluated. RESULTS: Most centers used BBT in only 12%-31% of all performed biopsies, relying on histology alone for most diagnostic decisions. BBT indications varied across centers: 3 focused on histological no-rejection with clinical discrepancy (44%, 45%, and 70%), 2 on chronic or chronic-active antibody-mediated rejection (AMR; clinical discrepancy 44% and 48%), and 2 on borderline changes (clinical discrepancy 30% and 33%). BBT showed moderate agreement with histology (κ = 0.49), with similar discrepancy rates between high- and low-volume centers. Molecular AMR was found in 44% of probable AMR, 63% of active AMR, 63% of microvascular inflammation, C4d- and donor-specific antibody (DSA)-, 77% of chronic-active AMR, and 21% chronic AMR. Molecular T cell-mediated rejection (TCMR) was confirmed in 26% of histologically active TCMR, in 9% of chronic TCMR, and in 16% of borderline changes. In histologic no-rejection cases, molecular AMR was present in 10% of DSA- and 34% of DSA+ biopsies. CONCLUSIONS: A moderate discrepancy between histology and MMDx sign-outs was found regardless of the center volume. BBT indications notably varied among centers. Standardized indications should be defined to improve the integration of molecular diagnostics into routine care.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25020322
003      
CZ-PrNML
005      
20251014150332.0
007      
ta
008      
251007s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/TXD.0000000000001848 $2 doi
035    __
$a (PubMed)40979586
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hruba, Petra $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
245    10
$a Intercenter Variability in the Application of Biopsy-based Transcriptomics in Kidney Transplantation / $c P. Hruba, E. Girmanova, M. Novotny, T. Reischig, I. Gala, MM. Kubisova, Z. Lys, J. Zieg, Z. Zilinska, I. Dedinska, K. Krejci, M. Konkolova, V. Hanzal, P. Mrazova, L. Capkova, L. Voska, M. Kment, O. Viklicky
520    9_
$a BACKGROUND: Biopsy-based transcriptomics (BBT) was implemented in Central Europe in 2022 to improve kidney transplant diagnostics. Differences in diagnostic practices across transplant centers remain underexplored. METHODS: This retrospective multicenter study analyzed 474 kidney graft biopsies from 10 transplant centers between August 2022 and May 2024, where, besides routine histology, BBT using the Molecular Microscope Diagnostic System (MMDx) was performed. Differences in BBT indications and discrepancies between histology assessment by Banff 2022 and MMDx sign-outs among transplant centers were evaluated. RESULTS: Most centers used BBT in only 12%-31% of all performed biopsies, relying on histology alone for most diagnostic decisions. BBT indications varied across centers: 3 focused on histological no-rejection with clinical discrepancy (44%, 45%, and 70%), 2 on chronic or chronic-active antibody-mediated rejection (AMR; clinical discrepancy 44% and 48%), and 2 on borderline changes (clinical discrepancy 30% and 33%). BBT showed moderate agreement with histology (κ = 0.49), with similar discrepancy rates between high- and low-volume centers. Molecular AMR was found in 44% of probable AMR, 63% of active AMR, 63% of microvascular inflammation, C4d- and donor-specific antibody (DSA)-, 77% of chronic-active AMR, and 21% chronic AMR. Molecular T cell-mediated rejection (TCMR) was confirmed in 26% of histologically active TCMR, in 9% of chronic TCMR, and in 16% of borderline changes. In histologic no-rejection cases, molecular AMR was present in 10% of DSA- and 34% of DSA+ biopsies. CONCLUSIONS: A moderate discrepancy between histology and MMDx sign-outs was found regardless of the center volume. BBT indications notably varied among centers. Standardized indications should be defined to improve the integration of molecular diagnostics into routine care.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Girmanova, Eva $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Novotny, Marek $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Reischig, Tomas $u Department of Nephrology, University Hospital Pilsen, Pilsen, Czech Republic
700    1_
$a Gala, Igor $u Department of Transplantation, Louis Pasteur University Hospital, Kosice, Slovakia
700    1_
$a Kubisova, Michaela Matyskova $u Department of Nephrology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
700    1_
$a Lys, Zdenek $u Department of Internal Medicine and Cardiology, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Zieg, Jakub $u Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Zilinska, Zuzana $u Department of Nephrology and Kidney Transplantations, University Hospital Bratislava, Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Dedinska, Ivana $u Department of Transplantation and Nephrology, University Hospital Martin and Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia
700    1_
$a Krejci, Karel $u 3rd Department of Internal Medicine - Nephrology, Rheumatology and Endocrinology, Faculty of Medicine and Dentistry, University Hospital, Olomouc, Czech Republic
700    1_
$a Konkolova, Martina $u F.D. Roosevelt University Hospital with Policlinic Banská Bystrica, Banská Bystrica, Slovakia
700    1_
$a Hanzal, Vladimir $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Mrazova, Petra $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Capkova, Lucie $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Voska, Ludek $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Kment, Martin $u Department of Clinical and Transplant Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Viklicky, Ondrej $u Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/0000000310492195 $7 nlk20050170291
773    0_
$w MED00195744 $t Transplantation direct $x 2373-8731 $g Roč. 11, č. 10 (2025), s. e1848
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40979586 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20251007 $b ABA008
991    __
$a 20251014150339 $b ABA008
999    __
$a ok $b bmc $g 2410786 $s 1258478
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 11 $c 10 $d e1848 $e 20250918 $i 2373-8731 $m Transplantation direct $n Transplant Direct $x MED00195744
LZP    __
$a Pubmed-20251007

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace